Pressure Continues for TPP to Include Biologic Exclusivity
As the Trans-Pacific Partnership (TPP) talks head into their 14th round early next month, U.S. lawmakers continue to press the president to ensure the negotiations protect the 12-year data exclusivity for biologics.
Such protection is needed for U.S. biotechs to compete on a level playing field and to safeguard the health of the nation's life sciences industry, Sen. Claire McCaskill (D-Mo.) said in a recent letter to the president.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter